See also this year's filing and all EDGAR filings for this company.
PDF Report 0001840904_2023_ATAI_Life_Sciences_N_V.pdf
Logs
info | Added remainder_ComprehensiveNetIncome directly from 10K | industry.us_generic | {} |
Graph
Absolute values for 0001840904, ATAI Life Sciences N.V.
xvar | xval | |
---|---|---|
0 | AssetsCurrent | 287,145,000 |
1 | IntangibleAssetsNetIncludingGoodwill | 0 |
2 | PropertyPlantAndEquipmentNet | 928,000 |
3 | remainder_Assets | 17,368,000 |
4 | LiabilitiesCurrent | 19,897,000 |
5 | LiabilitiesNoncurrent | 3,708,000 |
6 | remainder_Liabilities | 16,070,000 |
7 | CostOfGoodsAndServicesSold | 0 |
8 | SellingGeneralAndAdministrativeExpense | 70,350,000 |
9 | ResearchAndDevelopmentExpense | 74,313,000 |
10 | remainder_Expenses | 6,586,000 |
11 | remainder_Revenues | 233,000 |
12 | remainder_NetIncome | -6,401,000 |
13 | remainder_ComprehensiveNetIncome | -8,384,000 |
yvar | yval | |
---|---|---|
0 | Assets | 305,441,000 |
1 | Liabilities | 39,675,000 |
2 | Expenses | 151,249,000 |
3 | Revenues | 233,000 |
4 | StockholdersEquity | 265,766,000 |
5 | NetIncome | -157,417,000 |
6 | ComprehensiveNetIncome | -161,609,000 |
7 | BaseVar | 255,691,500 |
8 | EconomicCapitalRatio | 1.71 |